PRESS RELEASE published on 04/18/2023 at 08:00, 3 years 3 months ago Biophytis Announces 2022 Financial Results and 2023 Perspectives
PRESS RELEASE published on 04/17/2023 at 23:00, 3 years 3 months ago Biophytis: Results of the Combined General Meeting on April 17, 2023
PRESS RELEASE published on 03/30/2023 at 23:00, 3 years 4 months ago Biophytis: The Combined General Meeting will be held on second call on April 17, 2023
PRESS RELEASE published on 03/27/2023 at 08:00, 3 years 4 months ago Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 4 months ago Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years 5 months ago Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
PRESS RELEASE published on 03/02/2023 at 00:00, 3 years 5 months ago Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1
PRESS RELEASE published on 02/27/2023 at 08:00, 3 years 5 months ago Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of
PRESS RELEASE published on 02/23/2023 at 08:00, 3 years 5 months ago : Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023
PRESS RELEASE published on 02/02/2023 at 08:00, 3 years 6 months ago Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19
Published on 08/10/2026 at 21:35, 16 minutes ago Sekur Private Data Government Team Attending DoDIIS Worldwide Intelligence Conference
Published on 08/10/2026 at 20:30, 1 hour 21 minutes ago Clean Air Metals and Fiore-backed Springbok Ventures Announce Upsize of Non-Brokered Private Placement
Published on 08/10/2026 at 15:30, 6 hours 21 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 6 hours 26 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 7 hours 21 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 20:24, 1 hour 26 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 2 hours 16 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 18:29, 3 hours 21 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 17:50, 4 hours 1 minute ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 08/10/2026 at 17:38, 4 hours 13 minutes ago PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026
Published on 08/10/2026 at 18:00, 3 hours 51 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 9 hours 57 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 10 hours 14 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 12 hours 28 minutes ago Number of shares and voting rights - July 2026 (In French only)
